BioFire Diagnostics

BioFire Diagnostics

A biotech company that detects pathogens and mutations for molecular diagnostics. Learn more
  • Edit
DateInvestorsAmountRound
*
N/A

$45.0m

Debt

$25.0m

Late VC

$45.0m

Late VC
*

$450m

Valuation: $450m

Acquisition
Total Funding$70.0m

Recent News about BioFire Diagnostics

Edit
More about BioFire Diagnosticsinfo icon
Edit

BioFire Diagnostics, LLC, a leader in syndromic infectious disease testing, operates in the in vitro diagnostics market. This company specializes in molecular diagnostics, which involves analyzing biological markers in the genome and proteome to diagnose diseases. BioFire's flagship product, the BioFire System, is renowned for its speed, simplicity, and comprehensive testing capabilities. It can deliver accurate results in about one hour, making it a valuable tool for clinical laboratories that require around-the-clock molecular testing.

BioFire primarily serves clinical laboratories and healthcare providers who need rapid and reliable diagnostic tools to identify infections based on symptoms. The company’s syndromic testing approach allows for the simultaneous detection of multiple pathogens from a single patient sample, which is crucial for timely and accurate diagnosis. This method is particularly beneficial in identifying complex infections where symptoms may overlap, such as respiratory, gastrointestinal, and other infectious diseases.

The business model of BioFire Diagnostics revolves around the sale of its BioFire System and the associated test panels. These panels are designed to detect a wide range of pathogens, and the company generates revenue through the sale of these diagnostic kits. Additionally, BioFire offers ongoing support and maintenance services for its systems, ensuring that clients receive continuous and reliable performance.

BioFire Diagnostics operates globally, with FDA-cleared and CE IVD-marked assays, which means their products meet the regulatory standards in the United States and Europe. This global reach allows the company to support public health initiatives worldwide, reinforcing its mission to improve public health through advanced diagnostic solutions.

In summary, BioFire Diagnostics is a pioneering company in the field of molecular diagnostics, providing rapid and comprehensive syndromic testing solutions to clinical laboratories and healthcare providers. Their innovative BioFire System sets the standard for infectious disease diagnostics, ensuring accurate and timely results.

Keywords: syndromic testing, molecular diagnostics, infectious disease, BioFire System, clinical laboratories, rapid testing, pathogen detection, FDA-cleared, CE IVD-marked, public health.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.